Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The global cancer cryotherapy market is expected to grow at a CAGR of 8.1% during the period 2022-2027. North America, Asia and Europe are likely to be key markets.
With continual evolution of cancer treatment systems, novel treatments are emerging. Cryotherapy is one such system that is used to effectively kill cancer cells and treat cancer.
In cryotherapy, liquid nitrogen is usually used to generate extremely cold temperatures to kill abnormal tissue and cancer cells. While external tumours are generally treated by putting on liquid nitrogen directly through a cotton pad or a spraying tool. Post treatment, the frozen tissue turns into a scab, and heals with time. Cryotherapy is normally used to treat individuals with early-stage skin cancers, precancerous skin growth, and some forms of eye cancer.
For tumours within the body, a cryoprobe may be used to deliver cryotherapy.
In individuals with prostate cancer, cryotherapy is used to freeze cancer cells in the prostate. While cryosurgery may not be considered the first alternative to treat prostate cancer, it could be considered for those with low risk early-stage prostate cancer who are incapable of having surgery or radiation therapy.
Benefits of cryosurgery include smaller puncture or cut (for tumours occurring within the body), decreased pain and bleeding, use of local anesthesia, hospital stay may not be needed, decreased damage to tissue in proximity, safe repetition of treatment and possibility of supplementing with other treatment systems, suitability of use in case of tumours incapable of removal by surgery or age-related issues or other medical issues, available alternative in cases where cancer does not act in response to standard treatments.
Cryosurgery may employed in combination with other cancer treatments, like chemotherapy, hormone therapy, radiation therapy, immunotherapy, or surgery. To illustrate, remaining tissue post removal of primary bone tumour may be supplemented by cryotherapy to help decrease the risk that the tumour would reoccur.
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.